Initial Experiences with Subcutaneous Recombinant Human Hyaluronidase
Open accessThe DOI matches its Crossref record.
Abstract
We report here our retrospective observations on the use of recombinant human hyaluronidase (rHuPH20) for the facilitation of subcutaneous hydration and drug infusion. Thirty-two patients were treated with rHuPH20 in a hospice setting over a 6-month period. Of these, 26 received this agent to enhance hypodermoclysis with standard hydration fluids for symptom control of delirium, myoclonus and mild to moderate dehydration. Flow rates up to 500 mL/hr were attained without difficulty. Electrolyte replacement in hydration fluid was achieved without incident in 5 patients receiving potassium and in 1 patient receiving both potassium and magnesium. In addition to use for hydration, 6 patients received recombinant human hyaluronidase to enhance subcutaneous infusion of 9 medications, primarily because the medication dosage required subcutaneous flow rates greater than the standard 3 mL/hr. There were no significant adverse events. Induration at the infusion site occurred in 1 patient receiving hydration and higher than expected serum lidocaine concentration was observed in another patient. Based on our positive initial experience with recombinant human hyaluronidase, there is interest in expanding its use in our facility in both the inpatient and outpatient settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Understanding Clinical Dehydration and Its Treatment
Thomas, D. R., Cote, T. R., Lawhorne, L., Levenson, S. A., Rubenstein, L. Z., Smith, D. A., Stefanacci, R. G., Tangalos, E. G., & Morley, J. E. (2008) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2008.03.006 · Cited by 356
Insulin therapy and hypoglycemia
McCall, A. L. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.03.001 · Cited by 177
Peripheral Difficult Venous Access in Children
Rauch, D., Dowd, D., Eldridge, D., Mace, S., Schears, G., & Yen, K. (2009) · Clinical Pediatrics · doi:10.1177/0009922809335737 · Cited by 80
Difficult peripheral venous access: recognizing and managing the patient at risk
Walsh, G. (2008) · Journal of the Association for Vascular Access · doi:10.2309/java.13-4-7 · Cited by 58
A Systematic Data Review of the Cost of Rehydration Therapy
Pershad, J. (2010) · Applied Health Economics and Health Policy · doi:10.2165/11534500-000000000-00000 · Cited by 15
Metadata
- Authors
- Pirrello, R. D., Ting Chen, C., & Thomas, S. H.
- Venue
- Journal of Palliative Medicine
- Publisher
- SAGE Publications
- Published
- 2007-08
- Volume
- 10
- Issue
- 4
- Pages
- 861-864
- ISSN
- 1096-6218 (ISSN-L)
- 1557-7740
- OpenAlex
- W1994180307
- Cited by
- 57
- References
- 0
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Initial Experiences with Subcutaneous Recombinant Human Hyaluronidase. https://app.cochat.ai/papers/10.1089/jpm.2007.0037
- The paper
- Pirrello, R. D., Ting Chen, C., & Thomas, S. H. (2007). Initial Experiences with Subcutaneous Recombinant Human Hyaluronidase. Journal of Palliative Medicine. https://doi.org/10.1089/jpm.2007.0037
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.